Cardiovascular pharmacology of anandamide

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 2-3, 2002, Pages 343-351

  Hogestatt E D ^a   Zygmunt, P M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; NEUROPEPTIDE; RIMONABANT; VANILLOID RECEPTOR; 2 ARACHIDONOYLGLYCEROL; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; DRUG RECEPTOR; HORMONE;

CARDIOVASCULAR SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HYPOTENSION; KNOCKOUT MOUSE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SENSORY NERVE; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; METABOLISM;

ANIMALS; ARACHIDONIC ACIDS; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGY; GLYCERIDES; HORMONES; HUMANS; HYPOTENSION; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0036019419     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0346     Document Type: Article

References (107)

1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
2. Cannabinoid pharmacology
3. An endogenous cannabinoid as an endothelium-derived vasorelaxant
4. Studies on the effects of anandamide in rat hepatic artery
5. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
6. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat
7. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries
8. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
9. Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery
10. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries
11. Involvement of sensory nerves in vasodilator responses to acetylcholine and potassium ions in rat hepatic artery
12. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
13. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
14. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
15. Mechanism of the hypotensive action of anandamide in anesthetized rats
16. Hemodynamic effects of cannabinoids: Coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors
17. Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinoldimethylheptyl in rats
18. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors
19. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart
20. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat
21. Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors
22. Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues
23. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits
24. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship
25. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse
26. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves
27. Systemic and portal hemodynamic effects of anandamide
28. Peripheral chemoreceptors and cardiovascular regulation
29. Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat
30. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery
31. Mesenteric vasodilation mediated by endothelial anandamide receptors
32. Production and physiological actions of anandamide in the vasculature of the rat kidney
33. 2+-induced relaxation
34. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery
35. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication
36. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle
37. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists
38. 2+ channel current
39. Cardiovascular afferents involved in regulation of peripheral vessels
40. Peptidergic sensory neurons in the control of vascular functions: Mechanisms and significance in the cutaneous and splanchnic vascular beds
41. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide
42. Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function
43. Sensory effects of capsaicin congeners I. Relationship between chemical structure and pain-producing potency of pungent agents
44. The capsaicin receptor: A heat-activated ion channel in the pain pathway
45. From worm to man: Three subfamilies of TRP channels
46. Analysis of the native quaternary structure of vanilloid receptor 1
47. Novel natural vanilloid receptor agonists: New therapeutic targets for drug development
48. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human
49. Vanilloid (Capsaicin) receptors and mechanisms
50. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons
51. The sensory-efferent function of capsaicin-sensitive sensory neurons
52. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
53. Impaired nociception and pain sensation in mice lacking the capsaicin receptor
54. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
55. Analysis of the effects of intravenously injected capsaicin in the rat
56. Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries
57. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed
58. Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: Is 2-arachidonoylglycerol a possible vasomodulator?
59. Functional CB1 cannabinoid receptors in human vascular endothelial cells
60. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues
61. Anandamide uptake by human endothelial cells and its regulation by nitric oxide
62. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: Coupling to nitric oxide release
63. 2+ in endothelial cells
64. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta
65. The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro
66. Substance P-induced relaxation and hyperpolarization in human cerebral arteries
67. Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factor
68. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: Focus on regulation of EDHF
69. Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin
70. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): Their affinities for cannabinoid receptors and pathways of inactivation
71. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor
72. Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid
73. Anandamide activates human platelets through a pathway independent of the arachidonate cascade
74. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid
75. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
76. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock
77. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
78. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
79. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice
80. 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor
81. Pharmacology of cannabinoid receptor ligands
82. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
83. The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery
84. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism
85. Functional role of high-affinity anandamide transport, as revealed by selective inhibition
86. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase
87. Fatty acid amide hydrolase: Biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2- arachidonoylglycerol, palmitoylethanolamide, and oleamide
88. Structural determinants for recognition and translocation by the anandamide transporter
89. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma
90. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404
91. The anandamide transport inhibitor AM404 activates vanilloid receptors
92. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity
93. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues
94. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
95. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
96. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
97. Control of pain initiation by endogenous cannabinoids
98. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel
99. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
100. Receptor-dependent formation of endogenous cannabinoids in cortical neurons
101. Aspects on the pathophysiology of migraine and cluster headache
102. Clinical perspectives of calcitonin gene related peptide pharmacology
103. Hypotension- and endotoxin-induced alterations in calcitonin gene-related peptide: Modulation by dexamethasone
104. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase
105. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide
106. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1
107. Induction of vanilloid receptor channel activity by protein kinase C